Recognition of Non-operating Income, Non-operating Expenses and Extraordinary Loss
Perseus Proteomics Inc. (filing company)
The Company's fixed assets (individual locations and asset names Not disclosed)
The impairment loss on fixed assets was recognized in accordance with the Accounting Standard for Impairment of Fixed Assets. The specific causes of the foreign exchange gains, interest income, expenses related to the issuance of share acquisition rights and share issuance costs are Not disclosed.
Non-operating income: foreign exchange gains of ¥3.985 million and interest income of ¥939 thousand. Non-operating expenses: expenses related to the issuance of share acquisition rights of ¥1.572 million and share issuance costs of ¥756 thousand. Extraordinary loss: impairment loss of ¥516 thousand.
Cumulative first quarter of the fiscal year ending March 2027
No impact on the earnings forecast was stated. The above information is reflected in the “Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 2027 [Japanese GAAP] (Non-Consolidated)” published today.
| Item | Details |
|---|---|
| Event name | Recognition of Non-operating Income, Non-operating Expenses and Extraordinary Loss |
| Subject Entity | Perseus Proteomics Inc. (filing company) |
| Target Locations / Products | The Company's fixed assets (individual locations and asset names Not disclosed) |
| Cause | The impairment loss on fixed assets was recognized in accordance with the Accounting Standard for Impairment of Fixed Assets. The specific causes of the foreign exchange gains, interest income, expenses related to the issuance of share acquisition rights and share issuance costs are Not disclosed. |
| Amount of Impact on Business Performance | Non-operating income: foreign exchange gains of ¥3.985 million and interest income of ¥939 thousand. Non-operating expenses: expenses related to the issuance of share acquisition rights of ¥1.572 million and share issuance costs of ¥756 thousand. Extraordinary loss: impairment loss of ¥516 thousand. |
| Accounting period in which recognized | Cumulative first quarter of the fiscal year ending March 2027 |
| Impact on Earnings Forecast | No impact on the earnings forecast was stated. The above information is reflected in the “Summary of Financial Results for the First Quarter of the Fiscal Year Ending March 2027 [Japanese GAAP] (Non-Consolidated)” published today. |
Items this document does not state (18)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The impairment loss on fixed assets was recognized in accordance with the Accounting Standard for Impairment of Fixed Assets. No specific reasons were stated for recognizing the other non-operating income and non-operating expenses.